Explores the impact of blurred boundaries between drug promotion and objective information on consumer health, access to appropriate health services, and the information on which treatment decisions are based.
Notes:
<p>Includes bibliographical references. --- Review, Network Fall 1998: Blurring the Boundaries: New Trends in Drug Promotion takes a critical look at the new "partnerships" between the pharmaceutical industry and health and social services. It examines new trends in the way medicines are marketed and points out the imbalance between the amount of money shovelled into pharmaceutical advertising and the amount put into independent research on the drugs advertised. Just in time for our own Health Protection Branch's "transition", Barbara Mintzes' study for Health Action International gives several recommendations on regulating and monitoring drug promotion. "At stake here," says Mintzes, "is whether consumer health or commercial interests are to be given priority."</p>
